Iressa 250mg Tablet 30s

Introduction to Iressa 250mg Tablet 30s

Iressa 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer has certain genetic mutations called EGFR mutations. This medication is often prescribed to patients who have not undergone chemotherapy before.

Composition of Iressa 250mg Tablet 30s

The active ingredient in Iressa is Gefitinib, which is a type of drug known as an EGFR tyrosine kinase inhibitor. This means it works by blocking specific signals that promote cancer cell growth.

Uses of Iressa 250mg Tablet 30s

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancers with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Iressa 250mg Tablet 30s

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Iressa 250mg Tablet 30s

Before taking Iressa, it is important to consider the following precautions:

• Do not take if you do not have EGFR mutations.
• Avoid if you are pregnant or breastfeeding.
• Not recommended for individuals with severe liver or kidney disease.
• Should not be used by those with a history of interstitial lung disease.
• Avoid if allergic to Gefitinib or any of its ingredients.

How to Take Iressa 250mg Tablet 30s

• Take one 250 mg tablet once daily.
• Consume orally with water.
• Try to take it at the same time each day for consistency.

Conclusion of Iressa 250mg Tablet 30s

Iressa 250mg Tablet is a targeted therapy for certain types of lung cancer, specifically those with EGFR mutations. While it offers significant benefits, it is crucial to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.